Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials
Harsha Shanthanna, Ian Gilron, Manikandan Rajarathinam, et al.
PLoS Medicine (2017) Vol. 14, Iss. 8, pp. e1002369-e1002369
Open Access | Times Cited: 151

Showing 26-50 of 151 citing articles:

Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain
Jurga Bernatonienė, Arūnas Ščiupokas, Dalia M. Kopustinskienė, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1799-1799
Open Access | Times Cited: 12
Gabapentinoids: a therapeutic review
Akshay Athavale, Bridin Murnion
Australian Prescriber (2023) Vol. 46, Iss. 4, pp. 80-85
Open Access | Times Cited: 11
Concurrent Gabapentin and Opioid Use and Risk of Mortality in Medicare Recipients with Non‐Cancer Pain
M. Corriere, Laura L. Daniel, Alyson L. Dickson, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 5, pp. 1050-1057
Open Access | Times Cited: 10
Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study
Andrea L. Schaffer, Doreen Busingye, Kendal Chidwick, et al.
BJGP Open (2020) Vol. 5, Iss. 1, pp. bjgpopen20X101120-bjgpopen20X101120
Open Access | Times Cited: 27
Medication recommendations for treatment of lumbosacral radiculopathy: A systematic review of clinical practice guidelines
Morgan R. Price, Kaelyn E. Mead, Diana M. Cowell, et al.
PM&R (2024) Vol. 16, Iss. 10, pp. 1128-1142
Closed Access | Times Cited: 3
Fourteen-Year Trends in the Use of Psychotropic Medications, Opioids, and Other Sedatives Among Institutionalized Older People in Helsinki, Finland
Hanna‐Maria Roitto, Hannu Kautiainen, Ulla L. Aalto, et al.
Journal of the American Medical Directors Association (2019) Vol. 20, Iss. 3, pp. 305-311
Closed Access | Times Cited: 29
Safety of Gabapentin Prescribed for Any Indication in a Large Clinical Cohort of 571,718 US Veterans with and without Alcohol Use Disorder
Christopher T. Rentsch, Kenneth L. Morford, David A. Fiellin, et al.
Alcoholism Clinical and Experimental Research (2020) Vol. 44, Iss. 9, pp. 1807-1815
Open Access | Times Cited: 25
A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain
Soledad Giménez Campos, Pedro Mingoni Pimenta, Jose Israel Díaz-Cambronero, et al.
Atención Primaria (2021) Vol. 54, Iss. 1, pp. 102144-102144
Open Access | Times Cited: 22
Assessment of Pregabalin Postapproval Trials and the Suggestion of Efficacy for New Indications
Carole A. Federico, Taiji Wang, A. Doussau, et al.
JAMA Internal Medicine (2018) Vol. 179, Iss. 1, pp. 90-90
Closed Access | Times Cited: 27
Evaluation of Primary Care Physician Chronic Pain Management Practice Patterns
David Provenzano
Pain Physician (2018) Vol. 1, Iss. 21;1, pp. E593-E602
Open Access | Times Cited: 24
The best treatment option(s) for adult and elderly patients with chronic primary musculoskeletal pain: a protocol for a systematic review and network meta-analysis
Helen Koechlin, Ben Whalley, Nicky J. Welton, et al.
Systematic Reviews (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 24
Characterizing Gabapentinoid Use Among Patients With Isolated Low Back Pain
Gwyneth C. Maloy, Scott J. Halperin, Philip P. Ratnasamy, et al.
Global Spine Journal (2024)
Open Access | Times Cited: 2
Secular trends in gabapentinoid dispensing by compensated workers with low back pain: a retrospective cohort study
Stephanie Mathieson, Alex Collie, Christopher G. Maher, et al.
Occupational and Environmental Medicine (2024) Vol. 81, Iss. 5, pp. 245-251
Open Access | Times Cited: 2
Limitaciones, controversias y desafíos de las guías de práctica clínica sobre el manejo farmacológico del dolor neuropático
A. Alcántara Montero, P. Vidal
Medicina de Familia SEMERGEN (2024) Vol. 50, Iss. 7, pp. 102276-102276
Closed Access | Times Cited: 2
Umbrella Review of Primary Care Treatments for Adults With Chronic Low Back Pain
Filip Gedin, Tobias Sundberg, Vibeke Sparring, et al.
Journal of Manipulative and Physiological Therapeutics (2024)
Open Access | Times Cited: 2
Diagnosis and management of vulvodynia in postmenopausal women
Pedro Vieira‐Baptista, Gilbert Donders, Lynnette Margesson, et al.
Maturitas (2017) Vol. 108, pp. 84-94
Closed Access | Times Cited: 24
Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database
Leticia Ortiz de Landaluce, Pere Carbonell, Carmen Asensio, et al.
Drug Safety (2018) Vol. 41, Iss. 12, pp. 1325-1331
Open Access | Times Cited: 21
A repeated cross-sectional study of factors associated with pregabalin-positive poisoning deaths in Ireland
Ena Lynn, Gráinne Cousins, Suzi Lyons, et al.
Drug and Alcohol Dependence (2019) Vol. 206, pp. 107741-107741
Open Access | Times Cited: 21
A systematic review and meta-analysis of pregabalin preclinical studies
Carole A. Federico, Jeffrey S. Mogil, Tim Ramsay, et al.
Pain (2020) Vol. 161, Iss. 4, pp. 684-693
Closed Access | Times Cited: 19
Non-Invasive and Minimally Invasive Management of Low Back Disorders
Kurt T. Hegmann, Russell Travis, Gunnar Andersson, et al.
Journal of Occupational and Environmental Medicine (2020) Vol. 62, Iss. 3, pp. e111-e138
Open Access | Times Cited: 19
Placebo Response to Oral Administration in Osteoarthritis Clinical Trials and Its Associated Factors
Xin Wen, Jieren Luo, Yiying Mai, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2235060-e2235060
Open Access | Times Cited: 11
How to treat chronic pain in rheumatic and musculoskeletal diseases (RMDs) – A pharmacological review
Baptiste Gérard, F. Bailly, Anne‐Priscille Trouvin
Joint Bone Spine (2023) Vol. 91, Iss. 1, pp. 105624-105624
Open Access | Times Cited: 6
Effect of Mobile Device-Assisted N-of-1 Trial Participation on Analgesic Prescribing for Chronic Pain: Randomized Controlled Trial
David D. Odineal, Maria Marois, Deborah Ward, et al.
Journal of General Internal Medicine (2019) Vol. 35, Iss. 1, pp. 102-111
Open Access | Times Cited: 18
The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials
Marie Selvy, Mélissa Cuménal, Nicolas Kerckhove, et al.
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 6, pp. 707-733
Open Access | Times Cited: 17
Pain: Integration of Sensory and Affective Aspects of Pain
Junting Huang, Zizhen Zhang, Gerald W. Zamponi
Current Biology (2020) Vol. 30, Iss. 9, pp. R393-R395
Open Access | Times Cited: 16

Scroll to top